Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
about
Ring-Shaped Microlanes and Chemical Barriers as a Platform for Probing Single-Cell MigrationThe agar diffusion scratch assay--A novel method to assess the bioactive and cytotoxic potential of new materials and compounds.Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo.Sequential Salinomycin Treatment Results in Resistance Formation through Clonal Selection of Epithelial-Like Tumor Cells.Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogsSalinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.Single-Cell Migration as Studied by Scanning Electrochemical Microscopy.An in vitro study on the effects of the combination of salinomycin with cisplatin on human gastric cancer cellsAn iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors.Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.Metastasis review: from bench to bedside.Thy1 (CD90) Expression Is Elevated in Radiation-Induced Periprosthetic Capsular Contracture: Implication for Novel Therapeutics.Effects of salinomycin and 17‑AAG on proliferation of human gastric cancer cells in vitro.Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.Brefeldin A reduces anchorage-independent survival, cancer stem cell potential and migration of MDA-MB-231 human breast cancer cells.Salinomycin inhibits canine mammary carcinoma in vitro by targeting cancer stem cellsCombination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment.Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.Site-specific modification of the anticancer and antituberculosis polyether salinomycin by biosynthetic engineering.Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions.IGFBP-4 expression is adversely associated with lung cancer prognosis.Influence of salinomycin treatment on division and movement of individual cancer cells cultured in normoxia or hypoxia evaluated with time-lapse digital holographic microscopy.Ca2+ Selective Host Rotaxane Is Highly Toxic Against Prostate Cancer Cells.Insights into the Dual Activity of a Bifunctional Dehydratase-Cyclase Domain.Strategies to diversify natural products for drug discovery.Review and perspective on soft matter modeling in cellular mechanobiology: cell contact, adhesion, mechanosensing, and motility
P2860
Q27349210-798AD825-480D-4A92-8723-A365923AA280Q27349888-9204A3E9-E2E6-480E-B5E5-D7E7B12FA492Q33918405-222242B0-4674-4AEE-8DEA-34322892A88FQ35028765-9C882F86-42BF-4C09-BB22-158E0435EA76Q35932396-BADA5472-FBDA-4A3C-8FB9-5126D936A674Q35983858-44D53A7B-8FF3-42E2-8174-E03F59E999D6Q36233300-AE802F18-0074-4452-A0D2-6C116BEC20D2Q36408904-DA680B70-8C92-414B-ACFD-F1586186D07FQ36834993-AA2850E7-E1D6-44AC-94F9-FD2238321B95Q37580407-5CC76433-C593-467C-8792-9BADD2E86C6EQ38237985-FC18B3AF-F061-4C7B-946C-0314D3ACB6B4Q38660241-5C050A02-9762-4F50-A5F4-6632ECD34366Q38699905-31D6A79D-BC71-42A5-9DE4-66CFA8D5BB1AQ38866063-70CB68EA-1726-4DF7-A8A1-F76BBF596E68Q38943889-4F2EBEF8-121E-44D9-B279-15E8CAC50059Q40977870-DD9F2C62-E30E-46CC-968C-398563B9D7D8Q41584450-B0CAFD63-8AF7-4AC6-885E-F083DFC6A885Q42321600-1D7DB75D-E263-4491-BAA4-F8B6C0316D29Q42389843-7FD25394-122B-4549-A630-2854113B29FEQ42933366-07AF1B60-1C07-4E32-8A72-003C1E64B1D0Q47099007-84F9E2FE-FC72-483A-B912-86CFFD52C825Q47158789-4D5D6025-604D-4658-8D3D-5BADF7C61C3DQ47969307-03CC1AF8-4D23-480F-9413-ADCB75DD539AQ48102176-422F7D9F-F378-40A8-8E57-99FF8FB0B929Q48138855-5CD40E7D-69AB-4584-8625-513866577ACCQ57944920-824528BD-73F0-4F0E-BC89-5A43325FC2B2
P2860
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
@en
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration.
@nl
type
label
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
@en
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration.
@nl
prefLabel
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
@en
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration.
@nl
P2093
P2860
P356
P1433
P1476
Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration
@en
P2093
Adam Hermawan
Andreas Roidl
Annika Herrmann
Florian Kopp
Prajakta Shirish Oak
P2860
P2888
P356
10.1186/1476-4598-13-16
P50
P577
2014-01-27T00:00:00Z
P5875
P6179
1041798147